An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer

While the glycolytic regulator lactate dehydrogenase has been studied previously in breast cancer, this study offers an incisive advance by defining a crucial specific role for a particular isoform of this enzyme in a breast cancer subtype with few therapeutic options.